Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
AACR Cancer Progress Report 2015José Baselga, Nina Bhardwaj, Lewis C Cantley, et al.
Molecular Cancer Therapeutics|March 5, 2020
CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing SarcomaGuillermo Flores, Joel H Everett, Elissa A Boguslawski, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST ClinicChristopher B Weldon, Arin L Madenci, Sosipatros A Boikos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Sarcoma|August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
JAMA Oncology|March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor ClinicSosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
Cell Reports|January 19, 2016
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing SarcomaPatrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2015
AACR Cancer Progress Report 2015José Baselga, Nina Bhardwaj, Lewis C Cantley, et al.
Molecular Cancer Therapeutics|March 5, 2020
CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing SarcomaGuillermo Flores, Joel H Everett, Elissa A Boguslawski, et al.
Nature Medicine|October 18, 2005
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cellsHua Zhang, Kevin S Chua, Martin Guimond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST ClinicChristopher B Weldon, Arin L Madenci, Sosipatros A Boikos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2017
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing SarcomaChristine M Heske, Mindy I Davis, Joshua T Baumgart, et al.
Sarcoma|August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
JAMA Oncology|March 25, 2016
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor ClinicSosipatros A Boikos, Alberto S Pappo, J Keith Killian, et al.
Cell Reports|January 19, 2016
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing SarcomaPatrick J Grohar, Suntae Kim, Guillermo O Rangel Rivera, et al.
Pageof 22